It has been demonstrated that NSCLC-associated EGFR mutants appear to have impaired interactions with c-CBL, causing defective ubiquitination and degradation of EGFR, resulting in prolonged EGFR signaling [47, 48]. The gene discussed is CBL; the disease is non-small cell lung carcinoma.